# Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence

> **NCT02906683** · PHASE2 · COMPLETED · sponsor: **Taiho Pharmaceutical Co., Ltd.** · enrollment: 337 (actual)

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **DRUG:** TAS-303
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02906683
- **Lead sponsor:** Taiho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-20
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02906683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02906683, "Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02906683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*